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Abstract: The human Argonaute 2 (hAgo2) protein is a key player of RNA interference (RNAi).
Upon complex formation with small non-coding RNAs, the protein initially interacts with the 51-end
of a given guide RNA through multiple interactions within the MID domain. This interaction has
been reported to show a strong bias for U and A over C and G at the 51-position. Performing
molecular dynamics simulations of binary hAgo2/OH–guide–RNA complexes, we show that
hAgo2 is a highly flexible protein capable of binding to guide strands with all four possible 51-bases.
Especially, in the case of C and G this is associated with rather large individual conformational
rearrangements affecting the MID, PAZ and even the N-terminal domains to different degrees.
Moreover, a 51-G induces domain motions in the protein, which trigger a previously unreported
interaction between the 51-base and the L2 linker domain. Combining our in silico analyses with
biochemical studies of recombinant hAgo2, we find that, contrary to previous observations, hAgo2
is capable of functionally accommodating guide strands regardless of the 51-base.
Keywords: RNAi; MD; enzyme kinetics; pre-steady-state kinetics; fluorescence spectroscopy
1. Introduction
RNAi is a highly specific post-transcriptional mechanism, which regulates gene expression
through gene silencing. RNAi was initially discovered in the nematode Caenorhabditis elegans [1].
RNAi plays crucial roles in developmental processes and maintenance of cellular as well as systemic
homeostasis [2–5]. Thus far, more than 1800 human miRNAs have been identified [6]. It is assumed
that 20%–30% of human genes are likely regulated by miRNAs [7–10]. Aberrant expression and/or
function of miRNAs may cause several pathological states like various types of cancer as well as
metabolic, neurodegenerative, infectious, and chronic inflammatory diseases [11–13].
RNAi is a multi-step reaction and RNA-induced silencing complex (RISC) formation is central
to this process. RISC is a multi-protein complex that minimally consists of the Argonaute2 (Ago2)
protein and a miRNA or siRNA guide strand. miRNAs are small RNAs that are ~22 nucleotides (nt)
in length; they are known to ubiquitously regulate a wide range of eukaryotic cellular processes [14].
The double-stranded (ds) miRNA precursors are loaded into Ago2 with the thermodynamically
less stable 51-end strand preferred as a guide strand, while the passenger strand is released or
degraded [15,16].
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While the human Ago family consists of four members, hAgo1–4, all believed to be closely
associated with small RNAs, only hAgo2 embodies an endonucleolytic “slicer” activity [17,18].
Thus far, a range of Thermus thermophilus Argonaute (TtAgo) structures, in different combinations
of guide and target strands, have provided conclusive structural insights into the overall
architecture of Argonaute proteins [19–22]. The full-length eukaryotic crystal structures of human
and yeast Kluyveromyces polysporus Argonaute proteins revealed the eukaryotic counterparts [23–28].
Surprisingly, despite very low sequence identity (~12%) between hAgo2 and TtAgo, the architecture
of the protein is highly conserved; this is one of the finest examples of domain conservation over
sequence conservation [25].
hAgo2 is composed of four domains, N-terminal (N), PIWI-Argonaute-Zwille (PAZ), Middle
(MID) and P-element induced wimpy testes (PIWI), tethered by two linker domains, L1 and
L2 [23,25]. The structure is bilobed with a central cleft, which forms the nucleic acid binding
channel. One lobe consists of the N and PAZ domains and the other is formed by the MID and PIWI
domains. In hAgo2, eleven specific eukaryotic insertions were identified, compared to the prokaryotic
counterparts [29]. Three of these insertions are located in the nucleic acid binding channel, which
causes a lengthening of this structural feature. A specific eukaryotic C-terminal helical insertion
was also revealed, which carries several phosphorylation sites and is believed to play some role in
discriminating between a single stranded guide and a guide–target duplex [30].
The mode of small RNA binding to hAgo2 is comparable to the prokaryotic Agos: both
ends of the guide RNA are fixed, the 51-end by the MID domain and the 3’-end by the PAZ
domain [19–21,23,25]. The guide strand sits in a nucleic acid binding groove, with protruding side
chains of the neighboring protein residues introducing two major kinks in the RNA. In its course
across the protein, the guide RNA interacts with all four hAgo2 domains together with the two
linkers [23,25].
The 5’-end of the guide RNA forms a multitude of specific interactions with several residues in
a tight binding pocket of the MID domain [25,31]. A distinct loop known as the nucleotide specificity
(NS) loop, close to the MID binding pocket, binds the base of the 51-nucleotide [31]. Sequence analysis
performed on various nematode, fly, plant and conserved human miRNAs reveal that there is a strong
bias for U or A at the 51-position of the guide strand [31–35]. Crystal structures of the hAgo2 MID
domain in the presence of nucleoside monophosphates mimicking the 51-end of miRNAs shed some
light on this bias. The hydrogen-bonding patterns of CMP and GMP are completely opposite to
those of AMP and UMP. Furthermore, the amide group present in GMP collides with the carbonyl
group of G524 present in the NS loop. NMR titration experiments of an isolated hAgo2 MID domain
with nucleoside monophosphates further confirm this bias, as UMP and AMP have been shown to
have 30-fold higher binding affinity in comparison to CMP and GMP [31].This bias supposedly plays
a role in the loading of miRNA into Ago proteins with 51-U strands being strongly preferred [36].
Further confirmation originates from studies showing that the target nucleotide opposite the guide
51-nucleotide is bound within a binding pocket formed by the MIDand L2 domains of hAgo2 [28].
Biochemical analyses revealed an affinity up to three times higher for targets carrying an adenine
in this position. This might enhance dwell times of binary hAgo2–guide complexes on seed-paired
target RNAs [37].
In the present study, we combine molecular dynamics (MD) simulations of binary
hAgo2/OH–guide–RNA complexes with biochemical studies using full-length recombinant hAgo2
and different model RNA substrates to analyze the reported discrimination among different guide
51-nucleotides. We find hAgo2 to be highly flexible facilitating binding of guide strands comprising
all four possible nucleotides at the 51-end. Moreover, the different guides trigger subsequent target
RNA cleavage with comparable efficiency. Interestingly, conformational changes triggered by the
different guide strands not only affect the 51-binding pocked but also the PAZ and N domain to
different degrees.
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2. Results
We performed MD simulations making use of a recently published crystal structure of hAgo2
in complex with a bound guide miRNA (PDB 4F3T), to investigate the reported bias of hAgo2 for U
or A at the 51-position of the guide RNA in mechanistic terms. The MD simulations performed are
summarized in Table 1. To verify the in silico generated results, detailed steady- and pre-steady-state
binding and cleavage experiments with recombinant hAgo2 were conducted.
Table 1. List of simulations performed. For details, see Materials and Methods.
Chemical System Force Field MD Production Run Length
hAgo2 apo–enzyme Amber03 ILDN 100 ns
hAgo2_5’-U–guide AMBER Parmbsc0 100 ns
hAgo2_5’-A–guide AMBER Parmbsc0 100 ns
hAgo2_5’-C–guide AMBER Parmbsc0 100 ns
hAgo2_5’-G–guide AMBER Parmbsc0 100 ns
2.1. hAgo2 Is Stabilized by Protein–RNA Interactions
MD simulations of the hAgo2–miR20a complex reveal a breathing motion of the protein caused
by large movements of the N and PAZ domains (Figure 1). The movement and flexibility of the PAZ
domain dominates this breathing motion, although the L1 and L2 linker regions seem to regulate and
orchestrate it. The PAZ domain behaves like a pulley, tethered on both sides by the two-linker regions
acting like a fictitious rope, which pulls the N domain on one side and the MID/PIWI domains on the
other. Despite the large motions in the protein, the PIWI domain remains stable throughout, acting
like the core of the protein. Moreover, MD simulations of hAgo2 in the absence of bound guide RNA
confirm that the PAZ domain is the major contributor towards global protein flexibility. We observed
that the root mean square deviation (RMSD) of the PAZ domain increased from ~5 Å to >15 Å in the
absence of RNA, as shown in Figure 1b. This clearly indicates that the protein–RNA interactions are
integral in stabilizing the hAgo2–guide RNA complex.
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Figure 1 Analysis of backbone RMSD as a function of the simulation time for various hAgo2/guide 
RNA complexes. RMSD of the individual domains are calculated after superimposition on backbone 
atoms of the PIWI domain. (a) X-ray structure of full-length hAgo2 in complex with a truncated 10-
mer guide miRNA (PDB 4F3T). The individual domains are labeled and color-coded: N (blue), PAZ 
(magenta), MID (gold) and PIWI (green) joined by two linker regions, L1 (silver) and L2 (pale cyan). 
The protein is represented in cartoon and the guide RNA in licorice; (b) Free hAgo2 in the absence of 
bound guide RNA; and hAgo2–guide RNA complexes with U (c); A (d); C (e); or G (f) at the 5′-end of the RNA. 
Figure 1. Analysis of backbone RMSD as a function of the simulation time for vari us hAgo2/guide
RNA complexes. RMSD of the individual domains are calculated after superimposition on backbone
atoms of the PIWI domain. (a) X-ray structure of full-length hAgo2 in complex with a truncated
10-mer guide miRNA (PDB 4F3T). The individ al domains are labeled a d color-coded: N (blue),
PAZ (magenta), MID (gold) and PIWI (green) joined by two linker regions, L1 (silver) and L2 (pale
cyan). The protein is represented in cartoon and the guide RNA in licorice; (b) Free hAgo2 in the
absence of bound guide RNA; and hAgo2–guide RNA complexes with U (c); A (d); C (e); or G (f) at
the 51-end of the RNA.
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2.2. Different Guide 51-Bases Induce Different Inter-Domain Motion Patterns in hAgo2
To study the effect of the four possible 51-bases on the inter-domain motion of the hAgo2–guide
RNA complex, MD simulations were performed where the 51-U was replaced by A, C and G,
respectively. The simulations revealed that individual 51-base interactions differently affect the
observed inter-domain motions of hAgo2.
In the presence of a 51-U guide RNA, the hAgo2 domain motion is dominated by movements
of the PAZ and N domains, while MID and PIWI remain relatively stable (Figure 1c). As we replace
51-U with 51-A, the overall inter-domain motion pattern of hAgo2 is comparable to the situation with
5’-U (Figure 1d). In the presence of a 51-C, the inter-domain motion pattern changes and the protein
becomes more flexible (Figure 1e). The motion and flexibility of the N domain noticeably becomes
more explicit (Supplementary Material, Figure S1). However, hAgo2 retains its usual alternating
breathing motion caused by large movements of the PAZ domain. The MID domain appears less
flexible than observed for 51-U or 51-A, while the PIWI domain remains to be the least flexible of
all the domains, retaining its function as the core of the protein. Surprisingly, in the presence of
51-G, the inter-domain motion of hAgo2 is unique as compared to the other three bases showing an
antagonistic domain motion pattern (Figure 1f). Here, especially extensive movements of the MID
domain replace the conventional pattern dominated by movements of the PAZ domain. The RMSD
of the MID domain increases up to ~8 Å (Figure 1f). Additionally, the domain undergoes a rather
large conformational change (Supplementary Material, Figure S1). The PAZ and N domains also
contribute to these domain movements, whereas the behavior of the PIWI domain remains unaltered.
The RMSD means and standard deviations of individual domains of hAgo2 in presence of different
5’-bases, are summarized in Table 2.
Table 2. Mean and standard deviation of the RMSD calculated for hAgo2 protein domains in the
presence of different 51-bases (U, A, C, and G). The RMSD were calculated from the 100 ns MD
simulations after fitting on backbone atom of each domain separately.
Simulation System Name RMSD (Å)
N PAZ MID PIWI
hAgo2_guide RNA_51-U 0.72 ˘ 0.13 0.74 ˘ 0.18 0.42 ˘ 0.07 0.30 ˘ 0.03
hAgo2_guide RNA_51-A 0.61 ˘ 0.20 0.62 ˘ 0.17 0.45 ˘ 0.06 0.26 ˘ 0.02
hAgo2_guide RNA_51-C 0.73 ˘ 0.23 0.76 ˘ 0.23 0.35 ˘ 0.06 0.32 ˘ 0.05
hAgo2_guide RNA_51-G 0.59 ˘ 0.12 0.67 ˘ 0.14 0.84 ˘ 0.16 0.32 ˘ 0.03
The specific inter-domain protein motion pattern of hAgo2 is corroborated by the Principal
Component Analysis (PCA) of the trajectories in the presence of the respective 51-bases. PCA was
performed for the entire protein backbone. For each of the different 5’-bases a distinct pattern is
observable. In the presence of a 51-U the most pronounced domain motion is observed for the PAZ
domain (Figure 2a). The domain motion of hAgo2 is similar in the presence of 51-A with a correlated
motion of PAZ and parts of the N domain (Figure 2b). In the presence of 51-C the motion of the N
domain becomes more prominent than that of the PAZ domain (Figure 2c). Yet, the most striking
motion occurs in the presence of 51-G, where the MID domain shows an unusually high domain
motion, not observed for any of the other 51-bases (Figure 2d).
Differences in inter-domain motions of hAgo2 between the various systems were visualized
with the aid of cross-RMSD plots by comparing the 51-U simulation with all other systems. The
cross-RMSD plot for the MID domain (Figure 3a) shows that this domain is stable and does not show
much domain motion. However, a clear difference was observed for the N domain (Figure 3b). The
cross-RMSD values for the N domain constantly increase as we replace 51-U with 51-A, 51-G and 51-C.
This implies that the 51-base directly influences the motion of the N domain.
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2.3. Steady-State and Pre-Steady-State Binding Experiments of hAgo2 with Different Guide and
Target Substrates
We characterized the binding affinity as well as association and dissociation kinetics of various
binary (hAgo2/guide RNA) or ternary (hAgo2/guide/target RNA) complexes with steady-state and
pre-steady-state binding experiments. For a 21-mer 51-U RNA guide, we had previously determined
Kd values for binary complexes of 7 nM in the case of a 51-phosphorylated and 106 nM in the
case of an un-phosphorylated substrate [38]. Interestingly, here we observe quite the opposite for
a 5’-G guide: the 51-phosphorylated substrate shows a binding affinity of about 35 nM, whereas the
un-phosphorylated RNA binds with about 7 nM (Figure 4). The 51-A and 51-C guides show affinities
of in each case about 5 nM for the 51-phosphorylated and 8 nM and 7 nM for the un-phosphorylated
version, respectively. (Supplementary Material, Figure S2).
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Figure 4. Fluorescence equilibrium titrations of hAgo2 with guide RNA. 20 nM of FAM-labeled
guide RNA carrying a 51-G (s2b-FAM) without (a) or with (b) a phosphate group were titrated with
increasing amounts of hAgo2. Data were fitted to a quadratic equation and a representative fit is
shown. Kds of 7.5 ˘ 1.8 nM without a phosphate group and 34.7 ˘ 2.8 nM with a phosphate group at
the guide 51-end were obtained.
Performing transient binding experiments using a stopped flow device, we are able to dissect
the protein/RNA interaction in particular sub-steps [38]. Assembly of a binary hAgo2/guide
RNA complex comprises at least three kinetically distinct binding steps, with the first step (k+1)
representing a diffusion-limited collision complex formation. The second and third steps (k+2 and
k+3) represent anchoring of the guide strand 51-end into the Mid binding pocket and binding of the
guide strand 31-end to the PAZ domain, respectively. The corresponding dissociation rate constants
(k´1, k´2 and k´3) reflect the back-reaction. Accordingly, one would expect that especially motions
of the MID or PAZ domain might be reflected by changes of the association or dissociation rate
constants of the second and/or third step of binary complex formation; i.e., k+2/k´2 or k+3/k´3.
Interestingly, we indeed do observe slight changes upon 5'-U versus 5'-G guide/hAgo2 binary
complex dissociation while complex association is not affected (Supplementary Material, Figure S3).
While k´2 is accelerated by a factor of about 3, k´3 at the same time is reduced by a factor of about 3.
The corresponding data are summarized in Table 3. This would imply that domain motions triggered
by different 51-bases as shown in Figure 2 do, albeit to a small extent, affect transient hAgo2/guide
RNA interactions. In the case of ternary complex formation (hAgo2/guide/target), no differences
between different 5’-bases could be observed (data not shown).
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Table 3. Summary of equilibrium and pre-steady-state binding data for hAgo2/G–guide RNA
complex formation. Numbers in the first row represent equilibrium measurements (Kd_meas).
Numbers in the second column were calculated from the corresponding association and dissociation
rate constants (Kd_cal = koff/kon = (k´1/k1) ˆ (k´2/k2) ˆ (k´3/k3)). Differences in Kd values for binary
complexes determined via equilibrium and pre-steady-state measurements most probably arise from a
slight protein aggregation causing a reduced diffusion rate by 2–3-fold leading to an underestimating
of k+1_bin and thus higher Kd values. The numbers given are an average of at least two independent
experiments. Most experiments were repeated up to three or four times. Standard deviations are
given in brackets. * Data taken from [38]. Details are given in the text.
Substrate Kd_meas(nM)
Kd_cal
(nM) k1 (M
´1¨ s´1) k´1 (s´1) k2 (s´1) k´2 (s´1) k3 (s´1) k´3 (s´1)
U–guide * 7 ˘ 0.9 36 0.6 (˘0.001) ˆ 108 6.2 ˘ 0.6 0.26 ˘ 0.02 0.17 ˘ 0.02 0.012 ˘ 5 ˆ 10´4 0.007 ˘ 1 ˆ 10´4
G–guide 35 ˘ 0.4 59 0.16 (˘0.006) ˆ 108 2 ˘ 0.6 0.2 ˘ 0.06 0.54 ˘ 0.07 0.02 ˘ 0.01 0.0023 ˘ 4 ˆ 10´4
OH-G–guide 7 ˘ 0.5 21 0.27 (˘0.005) ˆ 108 2.1 ˘ 0.08 0.3 ˘ 0.2 0.6 ˘ 0.02 0.013 ˘ 0.002 0.002 ˘ 7 ˆ 10´4
2.4. Cleavage Assay with a 5’-G Guide RNA
Besides binding experiments, we also performed cleavage assays with a 21-mer guide RNA
bearing either 51-phosphorylated or un-phosphorylated 51-G in combination with a short 21-mer
target RNA fully complementary to the guide. As shown in Figure 5 the observed cleavage reactions
look the same. Moreover, the amplitude and the cleavage pattern were virtually indistinguishable
from results obtained previously with a 51-U guide [38]. A similar cleavage pattern could also be
observed for 51-A and 51-C guides (data not shown). This finding evidently suggests while the guide
5'-binding pattern might be different the overall Ago2/guide interaction is the same otherwise one
would not expect to observe an identical cleavage pattern.
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Figure 5. hAgo2-mediated cleavage of target RNA with guide strands carrying either a 5’-uridine or a
5’-guanosine with or without a 51-phosphate. Cleavage assays were conducted using 2.5 µM hAgo2,
100 nM guide RNA (as2b or G-as2b) and 2.5 nM target RNA (ICAM-1-IVT). Samples were taken at
time points 01, 51, 251, 551, and 1201 and analyzed using 8% denaturing PAGE. Detection was carried
out via autoradiography.
3. Discussion
While previous X-ray studies [31] have focused on the interaction of nucleoside monophosphates
with an isolated hAgo2 MID domain, here we were interested in the interaction of full length protein
and its corresponding guide strand. The starting point for our studies was a recently published
co-crystal structure of hAgo2 with a miRNA–20a guide RNA [25]. In addition to MD simulations
of different binary hAgo2/guide RNA complexes, we performed detailed biochemical studies to
complement our in silico data.
The co-crystal structures of the hAgo2 MID domain with different nucleoside monophosphates
(PDBs 3LUK, 3LUD, 3LUG and 3LUH) reveal that 51-UMP and 51-AMP have different interaction
Int. J. Mol. Sci. 2016, 17, 22 8 of 14
patterns from that of 51-CMP and 51-GMP. The bases of 51-UMP and 51-AMP form specific hydrogen
bonds with the backbone of T526 and G524, while 51-CMP and 51-GMP do not form hydrogen bonds,
since the amide group present in the pyrimidine ring of 51-GMP would clash with the carbonyl
group of G524. This interaction pattern has been used to explain the bias of hAgo2 towards 51-U
and 51-A and suggests that the human Ago family might go to great lengths to discriminate different
guide 5’-bases. It is tempting to speculate that hAgo proteins evolved in a manner to preferentially
accommodate miRNAs with 51-U over other 51-bases based on the sheer abundance of the human
miRNAs with 51-U [34].
In agreement with the X-ray studies mentioned above, we observed from our MD simulations
with full length protein bound to a 10-mer guide RNA that 51-U and 51-A ends retain the initial
interaction pattern with the NS loop through the entire length of the simulation (Figure 6a,b and
Supplementary Material, Figure S4a,b). In the case of a 51-C this interaction pattern is stabilized by the
formation of a novel hydrogen bond formation with the Q548 side chain (Supplementary Material,
Figure S4d,e). However, the most striking interaction pattern was observed between 51-G and the
neighboring protein residues. We noticed that the MID domain undergoes a large domain movement
at ~20 ns of the simulation, tilting the MID domain and bringing the NS loop in close proximity of
the L2 region. This movement triggers hydrogen bond formation between the NH2 and carbonyl
group of the 5’-G base and OD1 and OD2 of ASP358 present in helix7 of the L2 region. Once the
hydrogen bond formation occurs, it is retained thereafter for the entire remaining of the simulation.
In addition to this hydrogen bond interaction, perfect alignment of the aromatic rings of the base
with K525 side chain occurs, leading to a cation–pi interaction. This cation–pi interaction complements
the base stacking that already exists between the aromatic ring of the 51-G and the Y529 side chain
(Figure 6e). Y529 represents a highly conserved residue that has been shown to play a critical role
in guide RNA binding and, if phosphorylated, drastically reduces such interactions [39]. This novel
cation–pi interaction in addition to the stacking interaction between Y529 and 51-G pyrimidine ring
could explain the observed unexpected high binding affinity of about 7 nM of hAgo2 towards an
un-phosphorylated 51-G guide RNA (Table 3). Binding affinity for the phosphorylated guide is
about 34 nM. Interestingly, quite the opposite is true for a 5’-U guide. Here the phosphorylated
strand shows a binding affinity of about 7 nM whereas the un-phosphorylated version binds about
15-fold weaker. Obviously, in the case of 5'-U guides, hAgo2 discriminates strongly against the
un-phosphorylated RNA. As to why this has evolved in such a way we currently can only speculate.
It might have to do with the sheer abundance of human miRNAs with 51-U. For the remaining two
bases A and C no differences in binding affinity depending on the phosphorylation status could
be observed. As reflected by the binding experiments, the different guide strands, regardless if
51-phosphorylated or not, do not affect the hAgo2-mediated target RNA cleavage activity nor the
observed cleavage position.
Interestingly, there appears to be an inbuilt mechanism in hAgo2, which enables binding of all
four different guide 51-bases; it is not restricted to the MID binding pocket, but the entire protein, with
the exception of the PIWI domain, aids in this binding process by base-specific antagonistic domain
motions. Those inter-domain motions are especially pronounced in the presence of 51-C and 51-G
guide strands. The unique behavior of hAgo2 in the presence of 51-G is very intriguing since it is
completely opposite to that of 51-U. The PAZ domain is by far the most flexible domain of all and
contributes the most to different guide RNA binding patterns. The flexibility of the PAZ domain has
been documented previously [40,41], while conformational changes within the N and MID domains
have rarely been discussed.
Another interesting finding of this study is the novel interaction pattern observed between
the 51-G of the guide RNA and the L2 linker which occurred after ~20 ns into the simulation.
It is interesting to note that for the co-crystal structure of the hAgo2 MID domain with 51-GMP,
residual electron density was observed only for the phosphate and ribose of the nucleotide, whereas
the electron density of the base was notably missing [31]. This implies that a lack of stabilizing
Int. J. Mol. Sci. 2016, 17, 22 9 of 14
interactions between 51-G and the NS loop results in dynamic disorder in the crystal. The MID domain
experiences a domain movement, which brings it in the close proximity of helix7 of the L2 region
instigating a hydrogen bond formation between the 51-G and the D358 side chain. This suggests
that hAgo2 has to undergo additional domain movements and conformational changes in order to
accommodate the 5’-G in the most stable orientation. Once this arrangement is achieved, the 51-G of
the guide strand remains in this stable orientation. One of the prerequisites for this interaction is the
inward movement of the MID domain towards helix7 of the L2 region. Since the 51-end of the RNA is
tightly bound to the MID binding pocket the guide is also pushed deeper into the nucleic acid binding
channel, which in effect could influence the positioning and orientation of the incoming target strand.
On the other hand, our biochemical cleavage experiments do not support such a scenario. Then again,
the determined cleavage rate reflects the rate-limiting step of product release and thus might not be
suited to monitor conformational rearrangements affecting the chemical step [38].
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. Experimental Section
4.1. MD System Preparation
The crystal structure of hAgo2 (pdb: 4F3T) was used as starting point for all simulations.
The missing loop residues, excluding the unstructured N-terminus, were modelled using
Modeller9v10 [42]. The structure was first energy minimized in vacuum over 50,000 steps, applying
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the steepest descent method. It was then submerged in a box of 50,499 TIP3P water molecules
with periodic boundary conditions. Twenty-three counter ions were added to neutralize the system,
leading to a total of 150,703 atoms in each system. The solvated system was minimized over
50,000 steps and then equilibrated in two 100 ps simulations under NVT and NPT conditions,
respectively, with position restraints on the solute. For temperature coupling during the NVT
equilibration, the v-rescale thermostat was used. During NPT equilibration, the v-rescale thermostat
and Berendsen barostat were used for regulating the temperature and pressure of the system.
The equilibration of the system was performed at a reference temperature of 300 K. The position
restraints on the solute were then released to start the production run. Non-bonded interactions
were calculated using the Particle-Mesh-Ewald (PME) method with an order of 4 and a Fourier
spacing of 0.16. The non-bonded cutoff for the van der Waal (vdW) interactions was set to 1.0 nm.
Production runs of ~100 ns were performed for each system with a 2 fs integration time step. All MD
simulations were performed with the GROMACS 4.6 simulation package using either the Amber03
ILDN (apoenzyme) or the AMBER Parmbsc0 force field (nucleic acid bound enzyme) [43,44]. The
first simulation was carried out for the hAgo2 protein alone in the absence of guide RNA. The second
simulation was carried out for the hAgo2 in complex with a truncated guide RNA (nucleotides 1–10,
51-UAAAGUGCUU). In subsequent simulations, the U at the 5’-end of the guide RNA was replaced
by A, C or G, respectively.
4.2. Protein Expression and Purification
Recombinant full-length hAgo2 was expressed and purified as described recently [38].
4.3. Oligonucleotides
All oligonucleotides were obtained from IBA (Göttingen, Germany) or Biomers (Ulm, Germany).
Sequences of RNAs used for equilibrium fluorescence titrations, pre-steady-state stopped flow
measurements and cleavage assays are listed in Table S1 (Supplementary Material). Where
appropriate, RNAs were 51-phosphorylated, either with [γ-32P] ATP (Hartmann, Braunschweig,
Germany) or unlabeled ATP (Thermo Fisher Scientific, Waltham, MA, USA). In all cases, modified
RNAs were purified by using Sephadex-G-50 columns (GE Healthcare, München, Germany),
phenol/chloroform extraction, and ethanol precipitation.
4.4. Equilibrium Fluorescence Titrations
The binding affinity of recombinant hAgo2 in binding buffer (10 mM Tris, pH 7.5, 100 mM
KCl, and 0.5 mM MgCl2) to the different guide RNA strands was determined in a 700-µL cuvette,
where either FAM-labeled substrates (51-U or 51-G guide RNA; 20 nM each) or a binary complex
(600 nM hAgo2/20 nM 51-phosphorylated 51-U guide RNA (as2bFAM)) were titrated with increasing
concentrations of hAgo2 or a competitor 5’-A or 5’-C guide RNA, and change in fluorescence signal
was recorded by using the FluoroMax-3 fluorescence spectrometer (Horiba Jobin Yvon, Bensheim,
Germany). The samples were excited at 490 nm, and the emission intensity was measured at 520 nm.
Slits were set to 1 nm. The experimental data were either fitted to a quadratic equation using the
program GraFit 5, Fluorescence “ Fmax ´ Fmax ˆ
pS` E` Kdq
2
´
d
pS` E` Kdq2
4
´ Sˆ E
S
, where Fmax
is the maximum fluorescence, ∆Fmax is the maximal fluorescence change, S is the concentration of
substrate, E is the concentration of the enzyme, and Kd is the equilibrium dissociation constant, or in
the case of competitive titrations, they were evaluated by using the program Scientist (MicroMath
Scientific Software, Saint Louis, MO, USA), which allows the user to define the system under
investigation as a series of parallel equations defining (in this case) each discrete equilibrium, the
relationship between the total and free concentrations of the components, and the way in which the
observable signal is generated.
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4.5. Pre-Steady-State Stopped-Flow Measurements
For binary complex formation (hAgo2 and siRNA substrates), 20 nM fluorophore-labeled guide
RNA was rapidly mixed in binding buffer with hAgo2 (400–700 nM) and the change in fluorescence
signal was recorded over time using the stopped flow instrument SX20 (Applied Photophysics,
Leatherhead, UK). For the dissociation of binary complexes, 20 nM fluorophore-labeled guide RNA
was preincubated with 600 nM hAgo2 and then rapidly mixed with a 100-fold excess of non-labeled
competitor RNA. Excitation of the FAM-labeled RNAs was at 492 nm with slits set to 1 mm
(equivalent to a wavelength bandwidth of 4.65 nm) and detection was through a filter with a cut-off at
530 nm. Reaction rates k+n and k´n were calculated by fitting the experimental data to an exponential
equation using the program GraFit 5: Fluorescence =
ř
An ˆ ep´kn ˆ tq, where An is the amplitude
corresponding to the observed phase, kn is the rate constant of the observed phase and t is the time.
4.6. RNA Cleavage Assay
hAgo2 (2.5 µM) was incubated with 100 nM guide RNA (as2b or G-as2b) and 2.5 nM radiolabeled
target RNA (ICAM-1-IVT) at 37 ˝C for up to 2 h in 10 mM Tris, pH 7.5, 100 mM KCl, 2 mM MgCl2,
and 1 µg/mL RiboLock RNase Inhibitor (Fermentas). Reactions were stopped by addition of 1 vol
95% formamide, 0.025% (w/v) SDS, 0.025% (w/v) bromophenol blue, 0.025% (w/v) xylene cyanol,
0.5 mM EDTA, followed by PAGE analysis and autoradiography.
5. Conclusions
Our studies revealed that hAgo2 is a very flexible enzyme capable of functionally binding to
guide strands carrying each of the four possible nucleobases at the 5’-end. This result is surprising
and contradicts to some extent earlier observations made by others. However, one should consider
the present study was performed with full length protein and a 10-mer (MD simulations) or 21-mer
(biochemical studies) guide strand, while in other studies, an isolated MID domain and nucleoside
monophosphates were used. As such, these studies are not really comparable. While the simulations
with 51-U and 51-A guides closely resemble previous X-ray structures, hAgo2 has to undergo extensive
rearrangements in order to accommodate 51-C and 51-G guides as one would propose from the
aforementioned X-ray structures. Even though the MD simulations were performed in the absence of
a 51-phosphate group, our biochemical studies (e.g., binding studies of G–guide versus OH-G–guide)
are in strong support of the in silico analyses. Interestingly, only in the case of a 51-U guide the
51-phosphate leads to a strong bias. Whether or not this has anything to do with the abundance
of the human miRNAs with 51-U, we can currently only speculate. Of the four protein domains, PAZ
is the most flexible. Despite this, our MD simulations indicate that varying the guide 51-nucleobase
affects the entire protein rather than just the MID domain where 51-binding occurs. Then again,
according to our biochemical studies, such conformational rearrangements do not seem to interfere
with enzyme function. This observation might not be too surprising considering the additional
extensive conformational rearrangements upon formation of a catalytically active ternary complex
as can be derived from biochemical studies of hAgo2 [38,45] as well as bacterial Agos [46,47], and be
seen in different TtAgo/nucleic acid co-crystal structures [20,21].
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/17/
1/22/s1.
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